Back
Edgewise Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
EWTX
Edgewise Therapeutics
Last Price:
$25.30
Seasonality Move:
-12.14%
7 Day Trial
ALL ACCESS PASS
$
7

Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing slight buying pressure.
Edgewise Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.46 | Sell |
20-day SMA: | 26.27 | Sell |
50-day SMA: | 27 | Sell |
200-day SMA: | 24.86 | Buy |
8-day EMA: | 26.53 | Sell |
20-day EMA: | 26.61 | Sell |
50-day EMA: | 27.3 | Sell |
200-day EMA: | 24.93 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 42.69 | Sell |
Chaikin Money Flow: | -1528394 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Edgewise Therapeutics Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 25.19 while EWTX 8-day simple moving average is 26.46, which is a Sell signal.
-
The stock price of EWTX is 25.19 while Edgewise Therapeutics 20-day SMA is 26.27, which makes it a Sell.
-
Edgewise Therapeutics 50-day simple moving average is 27.00 while EWTX share price is 25.19, making it a Sell technically.
-
EWTX stock price is 25.19 and Edgewise Therapeutics 200-day simple moving average is 24.86, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Sell
33
Edgewise Therapeutics (EWTX)
is a Sell
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a SellThe current Edgewise Therapeutics [EWTX] share price is $25.19. The Score for EWTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
2.4B
Price in USD:
25.19
Share Volume:
2.3M
Edgewise Therapeutics 52-Week Range
52-Week High:
38.12
52-Week Low:
14.90
Sell
33
Edgewise Therapeutics (EWTX)
is a Sell
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?The Edgewise Therapeutics stock price is 25.19 USD today.
-
Will EWTX stock go up or go down?Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Edgewise Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is overvalued.
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 25.19 while EWTX 8-day exponential moving average is 26.53, which is a Sell signal.
-
The stock price of EWTX is 25.19 while Edgewise Therapeutics 20-day EMA is 26.61, which makes it a Sell.
-
Edgewise Therapeutics 50-day exponential moving average is 27.30 while EWTX share price is 25.19, making it a Sell technically.
-
EWTX stock price is 25.19 and Edgewise Therapeutics 200-day simple moving average is 24.93, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
-
EWTX Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting Edgewise Therapeutics is a Sell
-
Edgewise Therapeutics Relative Strength Index (RSI) is 42.69, which suggest Edgewise Therapeutics is oversold
-
The Bollinger Bands (25) for Edgewise Therapeutics is ( - ), which suggest Edgewise Therapeutics is a Buy
-
The Bollinger Bands (100) for Edgewise Therapeutics is ( - ), which suggest Edgewise Therapeutics is a Buy
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.